Use access key #2 to skip to page content.

IBDvalueinvestin (98.34)

Peter Kolchinsky a PH.D from Harvard in Virology has RA Capital

Recs

0

March 16, 2015 – Comments (2) | RELATED TICKERS: RGLS , BLUE , TRVN

Performance on fire. RA Capital posting third quarter returns of 51.5% and 1-year returns of 71.4% At which point does he become a God with a religious type following or has it started happening already?  
Read more at http://www.insidermonkey.com/blog/regulus-therapeutics-inc-rgls-trevena-inc-trvn-juno-therapeutics-inc-juno-ra-capitals-top-new-biotech-picks-339904/#MFZQvLYQ1fLafzV8.99

2 Comments – Post Your Own

#1) On March 16, 2015 at 9:21 PM, constructive (99.96) wrote:

He becomes a god with a religious following at the top of the bubble. At that point his religious followers suffer enormous losses.

Report this comment
#2) On March 17, 2015 at 4:41 PM, IBDvalueinvestin (98.34) wrote:

TRVN stock price is now only at $6+ and the consensus target is $17.

Its heart drug is in phase 2b stage.

 http://www.4-traders.com/TREVENA-INC-14934954/consensus/

 

BLUE though is almost at the consensus target of $124, trading at $121+.

 http://www.4-traders.com/BLUEBIRD-BIO-INC-13430435/consensus/

 

RGLS though is still well below consensus target of $33 with it trading around $19+

 http://www.4-traders.com/REGULUS-THERAPEUTICS-INC-11648682/consensus/

 

Report this comment

Featured Broker Partners


Advertisement